FDA Inspection 720198 — The Procter & Gamble Manufacturing Company

The Procter & Gamble Manufacturing Company — FEI 2021299

The FDA completed an inspection of The Procter & Gamble Manufacturing Company on April 15, 2011 in Phoenix, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 15, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Phoenix, AZ (United States)